Oligomerix Appoints Chief Medical Officer William Erhardt, M.D., to Board of Directors

Oligomerix to Participate in Upcoming Life Sciences Conferences

Oligomerix to Present at Upcoming Life Sciences Conferences

Oligomerix to Present at Clinical Trials on Alzheimer’s Disease Conference & Life Sciences Summit

Oligomerix Relocates Headquarters to Accommodate Growth

Oligomerix Receives $3.19 Million NIH Commercialization Readiness Pilot Grant for Alzheimer’s Disease Therapy

Oligomerix to Present at AAIC 2020 Conference on Small Molecule Inhibitor of Tau Self-Association

Oligomerix Appoints William Erhardt, M.D., as Chief Medical Officer

Oligomerix Announces Appointment of Robert Foerster, Former Pfizer Executive, as Chief Financial Officer

Oligomerix Presents Preclinical Data at TAU2020 Global Conference for Small Molecule Inhibitor of Tau Self-Association